{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T20:03:04Z","timestamp":1771876984416,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.cll.2025.10.001","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T12:20:03Z","timestamp":1764246003000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Implementation of the Individual Risk Assessment and Changes to Deferral Periods Since 2020"],"prefix":"10.1016","volume":"46","author":[{"given":"Todd","family":"Straus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Hermelin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Coberly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.cll.2025.10.001_bib1","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1111\/trf.17467","article-title":"The science, or not behind deferrals of blood donors with a history of cancer","volume":"63","author":"Gammon","year":"2023","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.cll.2025.10.001_bib2","doi-asserted-by":"crossref","first-page":"860","DOI":"10.2105\/AJPH.2021.306157","article-title":"Public policy impact of the COVID-19 pandemic on blood supply in the United States","volume":"111","author":"Riley","year":"2021","journal-title":"Am J Public Health"},{"key":"10.1016\/j.cll.2025.10.001_bib3","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1111\/trf.15869","article-title":"Expansion of hospital-based blood collections in the face of COVID-19 associated national blood shortage","volume":"60","author":"Gniadek","year":"2020","journal-title":"Transfusion"},{"issue":"S4","key":"10.1016\/j.cll.2025.10.001_bib4","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/trf.17359","article-title":"Impact of the COVID-19 pandemic on blood donation and transfusions in the United States in 2020","volume":"63","author":"Basavaraju","year":"2023","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.cll.2025.10.001_bib8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1046\/j.1537-2995.1991.31191096183.x","article-title":"Risk of human immunodeficiency virus transmission by blood transfusions prior to the implementation of HIV antibody screening in the San Francisco Bay area","volume":"31","author":"Busch","year":"1991","journal-title":"Transfusion"},{"issue":"10","key":"10.1016\/j.cll.2025.10.001_bib10","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1111\/trf.17515","article-title":"HIV risk behavior profiles among men who have sex with men interested in donating blood: findings from the assessing donor variability and new concepts in eligibility study","volume":"63","author":"Custer","year":"2023","journal-title":"Transfusion"},{"issue":"6 Pt 2","key":"10.1016\/j.cll.2025.10.001_bib11","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/trf.13632","article-title":"Transfusion-transmissible infection monitoring system: a tool to monitor changes in blood safety","volume":"56","author":"Custer","year":"2016","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.cll.2025.10.001_bib13","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/trf.16250","article-title":"HIV, HCV, and HBV incidence and residual risk in US blood donors before and after implementation of the 12-month deferral policy for men who have sex with men","volume":"61","author":"Steele","year":"2021","journal-title":"Transfusion"},{"key":"10.1016\/j.cll.2025.10.001_bib15","unstructured":"Foster T. Keys to success in Canada: Engagement, training, and communication. Presented at: AABB Hot Topic Discussion; January 26, 2023; Virtual."},{"issue":"8","key":"10.1016\/j.cll.2025.10.001_bib17","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1111\/trf.17000","article-title":"Staff perspectives on barriers and enablers to implementing alternative source plasma eligibility criteria for gay, bisexual, and other men who have sex with men","volume":"62","author":"Castillo","year":"2022","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.cll.2025.10.001_bib18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/trf.17175","article-title":"Communicating the move to individualized donor selection policy: framing messages focused on recipients and safety","volume":"63","author":"Ferguson","year":"2023","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.cll.2025.10.001_bib19","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/trf.18098","article-title":"How do we engage with the lesbian, gay, bisexual, and transgender community in blood donation and research? Reflections from the assessing donor variability and new concepts in eligibility study","volume":"65","author":"Crowder","year":"2025","journal-title":"Transfusion"},{"key":"10.1016\/j.cll.2025.10.001_bib20","first-page":"23","article-title":"ABC blood bulletin: individual donor risk assessment and blood safety","volume":"2","author":"Katz","year":"2023","journal-title":"Blood Bulletin"},{"key":"10.1016\/j.cll.2025.10.001_bib21","article-title":"Making blood donation more inclusive: the ADVANCE STUDY","author":"Crowder","year":"2023","journal-title":"Red Cross Plus Online"},{"key":"10.1016\/j.cll.2025.10.001_bib22","article-title":"Implementation of individual donor assessment in the USA and impact on rates of residual infectious disease. AABB annual meeting 2024, PL6-SN-25","volume":"64","author":"Townsend","year":"2024","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.cll.2025.10.001_bib23","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/trf.18195","article-title":"HIV incidence in US first-time blood donors during 12 and 3 month deferral policy periods between 2015 and 2023 before implementation of individual donor assessment","volume":"65","author":"Grebe","year":"2025","journal-title":"Transfusion"},{"issue":"344","key":"10.1016\/j.cll.2025.10.001_bib24","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJM200106283442603","article-title":"Transfusion-transmitted malaria in 779 the United States from 1963 through 1999","volume":"780","author":"Mungai","year":"2001","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.cll.2025.10.001_bib26","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1111\/j.1537-2995.2009.02290.x","article-title":"Risk for malaria in United States donors deferred for travel to malaria endemic areas","volume":"49","author":"Spencer","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.cll.2025.10.001_bib27","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.tmrv.2015.03.004","article-title":"The epidemiology of imported malaria and transfusion policy in 5 non-endemic countries","volume":"29","author":"O\u2019Brien","year":"2015","journal-title":"Transfus Med Rev"},{"issue":"12","key":"10.1016\/j.cll.2025.10.001_bib28","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1111\/trf.18061","article-title":"Laboratory detection of donors implicated in transfusion-transmitted malaria","volume":"64","author":"Galel","year":"2024","journal-title":"Transfusion"},{"key":"10.1016\/j.cll.2025.10.001_bib29","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1111\/trf.16606","article-title":"Supplemental findings of the 2019 national blood collection and utilization survey","volume":"61","author":"Mowla","year":"2021","journal-title":"Transfusion"},{"issue":"No 7","key":"10.1016\/j.cll.2025.10.001_bib30","article-title":"Blood supply challenges prompt action on donor eligibility","volume":"24","author":"Lawrence","year":"2022","journal-title":"AABB News"},{"issue":"2","key":"10.1016\/j.cll.2025.10.001_bib33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.tmrv.2011.07.007","article-title":"Donor testing and risk: current prevalence, incidence and residual risk of transfusion-transmissible agents in US allogeneic donations","volume":"26","author":"Zou","year":"2012","journal-title":"Transfus Med Rev"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271225000812?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271225000812?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T19:21:37Z","timestamp":1771874497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271225000812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0272271225000812"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2025.10.001","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implementation of the Individual Risk Assessment and Changes to Deferral Periods Since 2020","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2025.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}